NBA insider Shams Charania reported on NBA Countdown that Embiid directly approached Sixers owner Josh Harris to discuss the best course of action for his recovery. The former MVP had been managing persistent knee swelling throughout the season, receiving monthly injections to stay on the court.
Initially, there were differing views between Embiid and the organization regarding treatment, with the team believing he could continue playing while improving his conditioning. However, both sides have now aligned on a strategy focused on sustainable recovery.
Embiid, who was limited to just 19 games this season, averaged 23.8 points, 8.2 rebounds, and 4.5 assists in 30.2 minutes per game. His production dropped significantly compared to last year, when he led the league with 34.7 points per game before another injury cut his season short.
With Philadelphia sitting at 21-38 and struggling to stay in playoff contention, the focus has shifted toward ensuring Embiid returns at full strength next season. The franchise has a major investment in him, as he is owed up to $300 million over the next five years.
The Sixers have dealt with several injuries this season, and Embiid’s absence all but guarantees an uphill battle for the remainder of the schedule. The team will have to rely on Tyrese Maxey and Paul George to carry the load as they attempt to stay competitive.
While Embiid’s injury history remains a concern, Philadelphia’s decision to prioritize his health could have long-term benefits. The organization hopes a deliberate approach will help the seven-time All-Star stay on the court consistently moving forward.
